CINCINNATI--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced that President and CEO Joseph Gardner, will present at the 16th Annual Needham Healthcare Conference on Tuesday, April 4, 2017 at 10:00 a.m. Eastern Time at the Westin New York Grand Central Hotel. Dr. Gardner will provide a corporate overview and business update, including anticipated milestones for 2017 and will also be available to participate in one-on-one meetings with registered attendees.
About Aerpio Pharmaceuticals
Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead program, AKB‐9778, is a small molecule activator of the Tie2 pathway and is in clinical development for diabetic retinopathy. More information is available at www.aerpio.com.
